Stefan Frentzel

Title: Innovations of Stefan Frentzel: Pioneering Nogo-A Binding Molecules

Introduction

Stefan Frentzel, an accomplished inventor based in Lörrach, Germany, has made significant contributions to the field of pharmaceuticals. With two patents to his name, Frentzel has focused on developing binding molecules that play a crucial role in treating diseases of the nervous system. His work exemplifies the innovative spirit and dedication to advancing medical science.

Latest Patents

Frentzel's latest patents revolve around Nogo-A binding molecules and their pharmaceutical applications. These inventions provide a binding molecule capable of binding to the human NogoA polypeptide or human NiG with a dissociation constant of less than 1000 nM. The patents also cover a polynucleotide encoding such binding molecules, as well as expression vectors and systems designed to produce them. The potential applications of these molecules are particularly significant in the treatment of diseases affecting both the peripheral nervous system (PNS) and the central nervous system (CNS). Additionally, Frentzel outlines pharmaceutical compositions containing these binding molecules and methods for utilizing them effectively in clinical treatments.

Career Highlights

Stefan Frentzel's career includes notable positions at renowned institutions. He has worked with Novartis AG, a global healthcare company that brings innovative medicines to patients. Furthermore, his tenure at the University of Zurich has enriched his research and practical experience in the field of pharmaceuticals. These positions have allowed him to develop valuable knowledge and expertise that have contributed to his successful inventions.

Collaborations

Throughout his career, Frentzel has collaborated with distinguished colleagues, including Carmen Barske and Martin E Schwab. These partnerships have facilitated a sharing of knowledge and ideas, enhancing the depth and impact of their collective work in the pharmaceutical sector.

Conclusion

Stefan Frentzel's innovations in binding molecules for the treatment of nervous system diseases highlight his role as a key inventor within the pharmaceutical industry. His patents not only possess the potential to transform therapeutic approaches but also exemplify the collaborative and pioneering nature of scientific research and development. Frentzel's contributions will likely continue to influence advancements in medical science for years to come.